Lung Cancer

  1. Tecentriq (atezolizumab)
    Tecentriq (atezolizumab)
    by Roche Registration Limited
    for Urothelial Carcinoma, Lung Cancer
    €6,319.25
  2. Tagrisso (osimertinib)
    Tagrisso (osimertinib)
    by AstraZeneca AB
    for Lung Cancer
    €8,619.25
  3. Portrazza (necitumumab)
    Portrazza (necitumumab)
    by Eli Lilly Nederland B.V.
    for Lung Cancer
    €638.25
  4. Opdivo (nivolumab)
    Opdivo (nivolumab)
    by Bristol-Myers Squibb Pharma EEIG
    for Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €498.00
  5. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp & Dohme Limited
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €1,480.50
  6. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
    €1,134.60
  7. Alunbrig (brigatinib)
    Alunbrig (brigatinib)
    by ARIAD Pharmaceuticals, Inc.
    for Lung Cancer
    €3,657.00
  8. Alecensa (alectinib)
    Alecensa (alectinib)
    by Roche Registration GmbH
    for Lung Cancer
    €7,350.00
View as Grid List

8 Items

per page
Set Descending Direction